09:39 EDT Mirati Therapeutics trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MRTX:
- Mirati Therapeutics price target lowered to $31 from $40 at BMO Capital
- Mirati Therapeutics price target raised to $83 from $77 at Stifel
- Mirati Therapeutics assumed with an Overweight at Piper Sandler
- Mirati Therapeutics upgraded to Buy from Neutral at B. Riley
- Mirati Therapeutics 9.7M share Spot Secondary priced at $27.80